168 related articles for article (PubMed ID: 35144345)
1. [Analysis of experience in diagnosis and treatment of fetal goiter in patients with Graves' disease complicated with pregnancy].
Qin S; Sun WJ; Gao Y; Fan LX; Zhang Y; Huang JQ; Zhang XH; Guo HX; Yang H
Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):442-444. PubMed ID: 35144345
[TBL] [Abstract][Full Text] [Related]
2. Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
Washio K; Uenaka M; Tanimura K; Deguchi M; Nishida K; Fujioka K; Yamada H
Kobe J Med Sci; 2021 Feb; 66(4):E153-E158. PubMed ID: 33994519
[TBL] [Abstract][Full Text] [Related]
3. Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report.
Fujishima A; Sato A; Miura H; Shimoda Y; Kameyama S; Ariake C; Adachi H; Fukuoka Y; Terada Y
BMC Pregnancy Childbirth; 2020 Jun; 20(1):344. PubMed ID: 32493403
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine.
Bliddal S; Rasmussen ÅK; Sundberg K; Brocks V; Skovbo P; Feldt-Rasmussen U
Thyroid; 2011 Jan; 21(1):75-81. PubMed ID: 21162688
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
6. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. A case report.
Heckel S; Favre R; Schlienger JL; Soskin P
Fetal Diagn Ther; 1997; 12(1):54-8. PubMed ID: 9101225
[TBL] [Abstract][Full Text] [Related]
8. Fetal and neonatal thyroid function in relation to maternal Graves' disease.
Polak M; Le Gac I; Vuillard E; Guibourdenche J; Leger J; Toubert ME; Madec AM; Oury JF; Czernichow P; Luton D
Best Pract Res Clin Endocrinol Metab; 2004 Jun; 18(2):289-302. PubMed ID: 15157841
[TBL] [Abstract][Full Text] [Related]
9. Management of fetal goiters: 6-year retrospective observational study in three prenatal diagnosis and treatment centers of the Pays De Loire Perinatal Network.
Delay F; Dochez V; Biquard F; Cheve MT; Gillard P; Arthuis CJ; Winer N
J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2561-2569. PubMed ID: 30513035
[No Abstract] [Full Text] [Related]
10. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
Luton D; Le Gac I; Vuillard E; Castanet M; Guibourdenche J; Noel M; Toubert ME; Léger J; Boissinot C; Schlageter MH; Garel C; Tébeka B; Oury JF; Czernichow P; Polak M
J Clin Endocrinol Metab; 2005 Nov; 90(11):6093-8. PubMed ID: 16118343
[TBL] [Abstract][Full Text] [Related]
11. Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism.
Pyrżak B; Rumińska M; Witkowska-Sędek E; Kucharska A
Front Endocrinol (Lausanne); 2022; 13():877119. PubMed ID: 35600602
[TBL] [Abstract][Full Text] [Related]
12. Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism.
Ochoa-Maya MR; Frates MC; Lee-Parritz A; Seely EW
Thyroid; 1999 Nov; 9(11):1111-4. PubMed ID: 10595460
[TBL] [Abstract][Full Text] [Related]
13. A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidism.
Rotondi M; Bendotti G; Croce L; Molteni M; Carbone A; Magri F; Pearce EN; Chiovato L
Gynecol Endocrinol; 2022 Aug; 38(8):697-701. PubMed ID: 35723545
[No Abstract] [Full Text] [Related]
14. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
15. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
16. Therapy insight: management of Graves' disease during pregnancy.
Chan GW; Mandel SJ
Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations.
Volpé R; Ehrlich R; Steiner G; Row VV
Am J Med; 1984 Sep; 77(3):572-8. PubMed ID: 6548082
[TBL] [Abstract][Full Text] [Related]
18. Graves' hyperthyroidism in pregnancy.
Nguyen CT; Mestman JH
Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):232-240. PubMed ID: 31389810
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral iodide therapy on neonatal hyperthyroidism caused by maternal Graves' disease.
Maragliano G; Zuppa AA; Florio MG; Scapillati ME; Girlando P; Crescimbini B; Cafforio C; Noia G; Cavaliere AF; Tortorolo G
Fetal Diagn Ther; 2000; 15(2):122-6. PubMed ID: 10720879
[TBL] [Abstract][Full Text] [Related]
20. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy.
Cohen O; Pinhas-Hamiel O; Sivan E; Dolitski M; Lipitz S; Achiron R
Prenat Diagn; 2003 Sep; 23(9):740-2. PubMed ID: 12975785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
